Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -29.578% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COCCn1c(SCC(=O)Nc2cccnc2Cl)nc2cc(Cl)ccc2c1=O
b. COc1cccc2cc(C(=O)NCc3ccccn3)c(=O)oc12
Answer: a. COCCn1c(SCC(=O)Nc2cccnc2Cl)nc2cc(Cl)ccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCn1c(SCC(=O)Nc2cccnc2Cl)nc2cc(Cl)ccc2c1=O
COCCn1c(SCC(=O)Nc2cccnc2Cl)nc2cc(Cl)ccc2c1=O
2-[7-chloro-3-(2-methoxyethyl)-4-oxoquinazolin-2-yl]sulfanyl-N-(2-chloropyridin-3-yl)acetamide